Literature DB >> 1661865

Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats.

J L Junien1, M Gue, L Bueno.   

Abstract

The effects of neuropeptide Y and sigma ligands (d-NANM and JO 1784) on corticotropin-releasing factor (CRF) and psychological stress-stimulated caecal and colonic motility were evaluated by electromyography in rats equipped with chronically implanted electrodes on the caecum and proximal colon and a small catheter into the right lateral ventricle of the brain. Exposure to a psychological stress for 30 min increased significantly (P less than 0.05) the frequency of caecal and colonic spike bursts, an effect which was mimicked by intracerebroventricular administration of CRF (300 ng/kg). Injected intracerebroventricularly, 30 min prior to the psychological stress or intracerebroventricular administration of CRF, neuropeptide Y (150 ng/kg) abolished the excitatory effect on caeco-colonic motility. Similarly, prior administration of d-NANM (100 ng/kg) and JO 1784 (50 ng/kg) abolished the caeco-colonic hypermotility induced by psychological stress and intracerebroventricular injection of CRF. Four days after intracerebroventricular administration of pertussis toxin (150 ng/kg), both neuropeptide Y and JO 1784, when administered centrally, were unable to antagonize the stress-induced hyperkinesia. It is concluded that central administration of neuropeptide Y and sigma ligands abolish the stimulatory effects of psychological stress on caeco-colonic motility by blocking the pathways by which CRF activates the motility, through a common mechanism involving a pertussis toxin-sensitive Gi protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661865     DOI: 10.1016/0028-3908(91)90142-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

Review 1.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

2.  Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.

Authors:  I Shimizu; K Kawashima; D Ishii; M Oka
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat.

Authors:  M Matsuda; M Aono; M Moriga; M Okuma
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

4.  Attenuation by a sigma1 (sigma1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats.

Authors:  Johann Meunier; Michèle Gué; Max Récasens; Tangui Maurice
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

5.  Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; M Yoneda; H Mönnikes; J L Junien; Y Taché
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Reversal of CRF- and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat.

Authors:  M Gué; C Gleïzes-Escala; C Del Rio-Lacheze; J L Junien; L Buéno
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

7.  The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.

Authors:  F P Monnet; G Debonnel; R Bergeron; B Gronier; C de Montigny
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

8.  Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.

Authors:  M Gué; J L Junien; J R Reeve; J Rivier; D Grandt; Y Taché
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

9.  Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia.

Authors:  Yvette Taché; Mulugeta Million
Journal:  J Neurogastroenterol Motil       Date:  2015-01-31       Impact factor: 4.924

Review 10.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.